Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Coding Policy For Medicare Reversed To 'Promote Innovation'

Nov 03 2017

• By Cathy Kelly

Turn back sign

Related Content

What Renflexis Pricing Says About Medicare's Biosimilars Policy

Jul 28 2017

Biosimilars Payments In Medicare: CMS Signals Willingness To Change

Jul 17 2017

Medicare Coding Change For Biosimilars Could Save $65bn, Firms Say

Sep 14 2017

Related Companies

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

Additional Topics

United States Biosimilars Pricing Strategies BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window